ORTHOCELL LIMITED — Director's Dealing 2024

Jan 14, 2024

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity:	ORTHOCELL LIMITED
ABN 57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Kim Beazley
Date of appointment	15 January 2024

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of Securities Note: Provide details of the circumstances giving rise to the relevant interest. Nil Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	Letter of Appointment as a Director
Nature of interest	Options to be issued as part of terms and conditions of Director appointment under ListingRule 10.12 Exception 12.
Name of registered holder (if issued securities)	N/A
No. and class of securities to which interest relates	2,000,000unlisted options exercisable at $0.40 and expiring 5 years from date of issue.

• See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002